This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.
Michael E. Wiebe
Advertisement
Michael E. Wiebe, [email protected], is lead investigator, CAACB, and principal at Quantum Consulting, MIT Center for Biomedical Innovation.
Articles by Michael E. Wiebe
Advertisement
Latest Updated Articles
The Impact of SARS-CoV-2 on Biomanufacturing OperationsAugust 4th 2020
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
PharmTech Weekly Roundup—June 19, 2026
4
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
5